QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 277 filers reported holding QIAGEN NV in Q2 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $41,712,785 | -46.2% | 929,437 | -45.5% | 0.87% | -33.6% |
Q1 2023 | $77,461,249 | +75452.0% | 1,705,209 | -16.3% | 1.32% | +10866.7% |
Q4 2022 | $102,527 | -99.9% | 2,037,709 | -3.0% | 0.01% | -99.3% |
Q3 2022 | $88,448,000 | -13.2% | 2,099,666 | -3.4% | 1.62% | -8.1% |
Q2 2022 | $101,905,000 | -40.9% | 2,173,011 | -38.0% | 1.76% | -20.3% |
Q1 2022 | $172,426,000 | -13.4% | 3,502,250 | -2.0% | 2.21% | -24.5% |
Q4 2021 | $199,157,000 | +19.3% | 3,573,266 | +11.0% | 2.93% | +22.9% |
Q3 2021 | $166,892,000 | -27.9% | 3,218,670 | -32.8% | 2.39% | +32.8% |
Q2 2021 | $231,393,000 | -41.8% | 4,786,976 | -41.7% | 1.80% | -54.6% |
Q1 2021 | $397,895,000 | -53.5% | 8,215,122 | -50.2% | 3.96% | -60.5% |
Q4 2020 | $855,804,000 | -9.9% | 16,496,268 | -9.7% | 10.04% | -25.7% |
Q3 2020 | $949,472,000 | +292.1% | 18,274,007 | +225.1% | 13.50% | +130.8% |
Q2 2020 | $242,142,000 | +377.4% | 5,621,902 | +355.0% | 5.85% | +332.1% |
Q1 2020 | $50,721,000 | -36.7% | 1,235,685 | -47.7% | 1.35% | -25.0% |
Q4 2019 | $80,163,000 | – | 2,362,709 | – | 1.81% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |